Emerging evidence from in vivo PET imaging of TSPO protein (a marker of microglial activation) shows that neuroinflammation in the human brain is associated with neuropsychiatric symptoms and, importantly, the associations persist after accounting for confounders like amyloid and tau burden and cognitive impairment severity47,48. This evidence concerns the gene MAPT and Cognitive impairment.